TGTX(TG Therapeutics, Inc.) · 财务报表

TGTX(TG Therapeutics, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$6.69M$2.79M$233.66M$329.00M$616.29M
毛利润$5.90M$2.52M$219.53M$290.52M$515.57M
营业利润−$344.77M−$218.32M$20.63M$41.93M$123.32M
净利润−$348.10M−$223.81M$12.67M$23.38M$447.18M
经营现金流−$295.63M−$176.17M−$31.41M−$40.52M−$24.77M
自由现金流−$296.04M−$176.18M−$31.41M−$40.56M−$24.99M
摊薄每股收益$-2.63$-1.65$0.09$0.15$2.77

TG Therapeutics, Inc. TGTX